Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis
Open Access
- 1 October 1983
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 24 (4) , 529-532
- https://doi.org/10.1128/aac.24.4.529
Abstract
The pharmacokinetic parameters of ceftriaxone in eight patients with end-stage renal disease were determined during dialysis and during the interdialysis period. The mean half-life, clearance, and apparent volume of distribution during dialysis were 16 h, 722 ml/h, and 16.7 liters, respectively. During the interdialysis period, the half-life was 14 h, clearance was 739 ml/h, and volume of distributions was 14 liters. Individual variability in plasma concentrations occurred even in patients with apparently normal hepatic function. Based on these parameters, a dose of 1 g every 24 h would yield concentrations in excess of the concentrations needed to inhibit most gram-positive and gram-negative aerobic species.This publication has 8 references indexed in Scilit:
- Pharmacokinetic characteristics of intravenous ceftriaxone in normal adultsAntimicrobial Agents and Chemotherapy, 1982
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Pharmacokinetics of ceftriaxone in humansAntimicrobial Agents and Chemotherapy, 1981
- Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporinAntimicrobial Agents and Chemotherapy, 1981
- Multiple Intravenous Dose Pharmacokinetics of Ceftriaxone in ManChemotherapy, 1981
- Pharmacokinetics of Rocephin®, a Highly Active New Cephalosporin with an Exceptionally Long Biological Half-LifeChemotherapy, 1981
- Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studiesAntimicrobial Agents and Chemotherapy, 1980
- Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporinAntimicrobial Agents and Chemotherapy, 1980